Adagio Medical Announces US FDA Investigational Device Exemption Approval With Conditions To Conduct A Clinical Study For Treatment Of Persistent Atrial Fibrillation Using The Ultra-Low Temperature Cryoablation SystemMarv Kogan2019-08-20T00:30:21-07:00August 19th, 2019|Read More
Adagio Medical Treats First Persistent Atrial Fibrillation Patient With One Shot+™ Cryoablation Catheter Utilizing Only Anatomical Markers For Accurate ImagingMarv Kogan2019-07-31T15:13:15-07:00July 31st, 2019|Read More
Adagio Medical’s Persistent Atrial Fibrillation Cryoablation Study Demonstrates Early Single-Treatment Results Superior To Ablation Devices Requiring Two ProceduresMarv Kogan2018-11-28T15:02:40-08:00November 28th, 2018|Read More
Adagio Medical Completes Chronic Pre-Clinical Atrial Fibrillation Study Using Ultra-Low Temperature Cryoablation TechnologyMarv Kogan2018-10-15T12:58:15-07:00October 4th, 2018|Read More
Adagio Medical Treats First Atrial Fibrillation Patients Using New One Shot+™ Cryoablation CatheterMarv Kogan2018-10-15T13:02:35-07:00October 1st, 2018|Read More
First Three Persistent Atrial Fibrillation Patients Enrolled In Adagio Medical CryoCure Study Using Cryolinear Ablation TechnologyMarv Kogan2018-10-15T13:06:17-07:00May 9th, 2017|Read More
